Providers in the Media
The government ignored a top health official’s warning against greenlighting a lucrative vaccine developed by a firm close to Ayatollah Khamenei
Despite exploding in popularity during the pandemic, telehealth has been around in healthcare for years. But the sudden shift to virtual care in 2020 forced the pace of innovation in health tech to accelerate—and some providers have struggled to keep up.
Practical Dermatology® magazine is proud to announce that Vishal Anil Patel, MD will serve as interim editor of our Digital Practice column.
People with skin conditions are open to trying medical cannabis products as potential treatments, according to a study from The George Washington University School of Medicine and Health Sciences and the University of Maryland.
Michael G. Knight, MD, MSHP, FACP, Associate Chief Quality and Population Officer, Head of Healthcare Delivery Transformation and Assistant Professor of Medicine, spoke with the Washington Post about proper masking and the reuse of KN95 and N95 masks during COVID.
CBD – or cannabidiol, the second most prevalent active ingredient in cannabis – and active cannabinoids are gaining attention in the beauty industry. Despite ongoing claims confusion, complex regulatory hurdles and a lack of consumer confidence due to greenwashing, the popularity is especially…
For the average human without a chronic scalp condition, going to the hair salon can feel like a real luxury. On the flip side, for folks with scalp psoriasis—a condition that impacts 45% to 56% of people living with the inflammatory skin disorder—a trip to the salon can be both stressful and…
Treatment for hyperhidrosis depends on where on your body you're sweating and may require trying different approaches, or a combination, to find relief.
Psoriasis is best known for its often red, raised, and flaky appearance on areas like the elbows, knees, and buttock, although it can affect other areas as well, including the scalp, Adam Friedman, MD, professor of dermatology at George Washington School of Medicine and Health Sciences,…
Adam Friedman, MD, a professor and chair of dermatology at the George Washington University School of Medicine and Health Sciences, comments on how the recent misinformation has forced him to change his strategy when discussing and prescribing Ivermectin to patients for legitimate uses.